药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
4-Methoxyamphetamine
Anisodamine
The risk or severity of QTc prolongation can be increased when Anisodamine is combined with Fostemsavir.
4-Methoxyamphetamine
Pazufloxacin
The risk or severity of QTc prolongation can be increased when Pazufloxacin is combined with Fostemsavir.
4-Methoxyamphetamine
Ebastine
The risk or severity of QTc prolongation can be increased when Ebastine is combined with Fostemsavir.
4-Methoxyamphetamine
Rupatadine
The risk or severity of QTc prolongation can be increased when Rupatadine is combined with Fostemsavir.
4-Methoxyamphetamine
Difloxacin
The risk or severity of QTc prolongation can be increased when Difloxacin is combined with Fostemsavir.
4-Methoxyamphetamine
Sarafloxacin
The risk or severity of QTc prolongation can be increased when Sarafloxacin is combined with Fostemsavir.
4-Methoxyamphetamine
Phosmet
The risk or severity of QTc prolongation can be increased when Phosmet is combined with Fostemsavir.
4-Methoxyamphetamine
Orbifloxacin
The risk or severity of QTc prolongation can be increased when Orbifloxacin is combined with Fostemsavir.
4-Methoxyamphetamine
Fenthion
The risk or severity of QTc prolongation can be increased when Fenthion is combined with Fostemsavir.
4-Methoxyamphetamine
Famphur
The risk or severity of QTc prolongation can be increased when Famphur is combined with Fostemsavir.
4-Methoxyamphetamine
Dichlorvos
The risk or severity of QTc prolongation can be increased when Dichlorvos is combined with Fostemsavir.
4-Methoxyamphetamine
Coumaphos
The risk or severity of QTc prolongation can be increased when Coumaphos is combined with Fostemsavir.
4-Methoxyamphetamine
Acrivastine
The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Fostemsavir.
4-Methoxyamphetamine
Lacidipine
The risk or severity of QTc prolongation can be increased when Lacidipine is combined with Fostemsavir.
4-Methoxyamphetamine
Efonidipine
The risk or severity of QTc prolongation can be increased when Efonidipine is combined with Fostemsavir.
4-Methoxyamphetamine
Aranidipine
The risk or severity of QTc prolongation can be increased when Aranidipine is combined with Fostemsavir.
4-Methoxyamphetamine
Dosulepin
The risk or severity of QTc prolongation can be increased when Dosulepin is combined with Fostemsavir.
4-Methoxyamphetamine
Pinaverium
The risk or severity of QTc prolongation can be increased when Pinaverium is combined with Fostemsavir.
4-Methoxyamphetamine
Trimebutine
The risk or severity of QTc prolongation can be increased when Trimebutine is combined with Fostemsavir.
4-Methoxyamphetamine
Vilanterol
The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Fostemsavir.